CAS 1000995-49-2: [(1aR,1bS,2R,2aS,5cR,9aR,10S,10aS,11aR,11bS,11cS,12aS,12bS)-1,1a,1b,2,2a,4,7,9,9a,10,10a,11,11a,11b,11c,12,12a,12b-Octadecahydro-2,2a,10,12a-tetrahydroxy-8-(hydroxymethyl)-1b,5,11b-trimethyl-4,7-dioxobiscyclopropa[4′,5′]cyclopenta[1′,2′,3′:1,10;2′′,1′′:7,8]phenanthro[3,4-b:4b,5-b′]difuran-10-yl]methyl (2E)-2-methyl-2-butenoate

Chloramultilide D is a macrolide polyketide, which is a natural product typically derived from microorganisms, particularly certain strains of bacteria. It is synthesized through complex polyketide biosynthesis pathways involving polyketide synthases. The mode of action of Chloramultilide D involves disrupting bacterial protein synthesis by targeting the ribosomal machinery. This interference with protein production can inhibit bacterial growth, potentially classifying it within a valuable subset of antimicrobial compounds. Due to these properties, Chloramultilide D is of significant interest in the field of antibiotic research, especially as a candidate for combatting resistant bacterial strains. Its potential applications extend to exploring novel therapeutic strategies and designing new drugs that can overcome current antibiotic resistance challenges. Ongoing studies are focused on elucidating its biosynthetic pathways and optimizing its production, as well as evaluating its efficacy and safety in pharmacological contexts. Scientists are particularly interested in its structural features, which could aid in rational drug design and development of analogous compounds.

Chloramultilide D is a natural product from Chloranthus spicatus.